Alkem Laboratories Continues Upward Trend with 1.08% Gain
Alkem Laboratories Ltd gains for third consecutive session
Business Standard
Image: Business Standard
Alkem Laboratories Ltd's stock rose by 1.08% to ₹5428.5 on the NSE, marking its third consecutive day of gains. Over the past year, the stock has increased by 11.07%, outperforming the NIFTY's 5.18% rise. However, it has seen a decline of 2.09% in the last month.
- 01Alkem Laboratories' stock price reached ₹5428.5, up 1.08% today.
- 02The stock has gained 11.07% over the past year.
- 03In contrast, the NIFTY index rose by 5.18% during the same period.
- 04Alkem's stock has decreased by 2.09% in the last month.
- 05The stock's price-to-earnings (PE) ratio is 29 based on trailing twelve months earnings.
Advertisement
In-Article Ad
Alkem Laboratories Ltd's stock price increased by 1.08% today, reaching ₹5428.5 as of 12:49 IST on the National Stock Exchange (NSE). This marks the third consecutive day of gains for the pharmaceutical company. Over the past year, Alkem's stock has appreciated by 11.07%, significantly outperforming the NIFTY index, which has risen by 5.18%, and the Nifty Pharma index, which has increased by 8.22%. Despite this annual growth, Alkem's stock has experienced a decline of 2.09% over the last month, while the Nifty Pharma index has dropped by 5.16%. Today's trading volume for Alkem stood at 34,997 shares, compared to an average of 1.27 lakh shares over the past month. The stock's price-to-earnings (PE) ratio is currently at 29, based on trailing twelve months earnings ending December 25.
Advertisement
In-Article Ad
Investors in Alkem Laboratories may see a positive trend in their investments, especially given the stock's annual growth. However, the recent monthly decline may prompt caution among potential investors.
Advertisement
In-Article Ad
Reader Poll
Do you think Alkem Laboratories will continue to rise in stock price?
Connecting to poll...
More about Alkem Laboratories Ltd
Read the original article
Visit the source for the complete story.